Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02433665Terminated
Randomised, open-label trial of iopamidol (2 arms), sponsored by Duke University. Primary endpoint: Variability in Enhancement Data at 5 minutes. Started Aug 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02433665.